Literature DB >> 30652681

Cytokine imbalance in patients with systemic sclerosis and resilience: the key role of interleukin-6.

Manuel Rojas1, Yhojan Rodríguez2, Diana M Monsalve2, Yovana Pacheco2, Yeny Acosta-Ampudia2, Mónica Rodríguez-Jimenez2, Nicolás Molano-González2, Rubén D Mantilla2, Carolina Ramírez-Santana2, Juan-Manuel Anaya3.   

Abstract

OBJECTIVES: Resilience, the ability to respond positively to adverse events, may be influenced by long-term stressors and autoimmune/inflammatory conditions such as systemic sclerosis (SSc). Since the immune system plays a role in the development of resilience, we aimed to evaluate the relationship between a panel of cytokines and resilience in patients with SSc.
METHODS: Thirty-five consecutive women with established SSc were involved in this exploratory study. Clinical characteristics, including severity of symptoms and resilience, a panel of 15 serum cytokines and 17 autoantibodies were assessed simultaneously. Multivariate methods were used to analyse the data.
RESULTS: Interleukin-6 (IL-6) levels were associated with severity of symptoms (β=1.8395, p=0.04), and low resilience scores (β= -0.581120, p=0.02). Furthermore, resilience was not associated with clinical manifestations nor polyautoimmunity. Cytokine levels did not significantly differ between groups based on regular physical activity.
CONCLUSIONS: The results highlight the importance of IL-6 as a key mediator in the altered cytokine network of SSc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30652681

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  2 in total

Review 1.  Pathogenetic Aspects of Systemic Sclerosis: A View Through the Prism of B Cells.

Authors:  Konstantinos Melissaropoulos; George Iliopoulos; Lazaros I Sakkas; Dimitrios Daoussis
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

2.  Resilience in women with primary Sjögren's syndrome.

Authors:  Roberta Priori; Federico Giardina; Raffaella Izzo; Angelica Gattamelata; Massimo Fusconi; Serena Colafrancesco; Giuseppe Curcio
Journal:  Rheumatol Int       Date:  2021-06-05       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.